Cargando…

Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease

Autologous hematopoietic stem cell (HSC)-targeted gene therapy provides a one-time cure for various genetic diseases including sickle cell disease (SCD) and β-thalassemia. SCD is caused by a point mutation (20A > T) in the β-globin gene. Since SCD is the most common single-gene disorder, curing S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Germino-Watnick, Paula, Hinds, Malikiya, Le, Anh, Chu, Rebecca, Liu, Xiong, Uchida, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180595/ https://www.ncbi.nlm.nih.gov/pubmed/35681538 http://dx.doi.org/10.3390/cells11111843

Ejemplares similares

Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
por: Uchida, Naoya, et al.
Publicado: (2021)

Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model
por: Uchida, Naoya, et al.
Publicado: (2023)

Therapy Development by Genome Editing of Hematopoietic Stem Cells
por: Koniali, Lola, et al.
Publicado: (2021)

Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
por: Park, So Hyun, et al.
Publicado: (2019)

Immunoresponse to Gene-Modified Hematopoietic Stem Cells
por: Drysdale, Claire M., et al.
Publicado: (2019)

Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing
por: Anurogo, Dito, et al.
Publicado: (2021)

Forced enhancer-promoter rewiring to alter gene expression in animal models
por: Peslak, Scott A., et al.
Publicado: (2023)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?
por: Rozen, Laurence, et al.
Publicado: (2019)

Hematopoietic Stem Cell Function in a Murine Model of Sickle Cell Disease
por: Javazon, Elisabeth H., et al.
Publicado: (2012)

Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions
por: Özdoğu, Hakan, et al.
Publicado: (2015)

Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
por: Aprile, Annamaria, et al.
Publicado: (2022)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Targeted Genome Editing in Human Repopulating Hematopoietic Stem Cells
por: Genovese, Pietro, et al.
Publicado: (2014)

In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations
por: Psatha, Nikoletta, et al.
Publicado: (2022)

Therapeutic adenine base editing of human hematopoietic stem cells
por: Liao, Jiaoyang, et al.
Publicado: (2023)

The p53 challenge of hematopoietic stem cell gene editing
por: Dorset, Sofie R., et al.
Publicado: (2023)

Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations
por: Bhatia, Monica, et al.
Publicado: (2015)

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review
por: Bhalla, Nishka, et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions
por: Jang, Tim, et al.
Publicado: (2021)

The hematopoietic saga of clonality in sickle cell disease
por: Stonestrom, Aaron J., et al.
Publicado: (2022)

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease
por: Limerick, Emily, et al.
Publicado: (2019)

Highly efficient therapeutic gene editing of human hematopoietic stem cells
por: Wu, Yuxuan, et al.
Publicado: (2019)

Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells
por: Salisbury-Ruf, Christi T., et al.
Publicado: (2021)

Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
por: Buffa, Valentina, et al.
Publicado: (2023)

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy
por: Kassim, Adetola A., et al.
Publicado: (2022)

Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
por: Azhagiri, Manoj Kumar K., et al.
Publicado: (2021)

Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells
por: Siegner, Sebastian M., et al.
Publicado: (2022)

Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion
por: Becker, Hans Jiro, et al.
Publicado: (2023)

Generation of hematopoietic stem/progenitor cells with sickle cell mutation from induced pluripotent stem cell in serum-free system
por: Paes, Bárbara C.M.F., et al.
Publicado: (2021)

Awareness and Acceptance of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Jazan Province, Saudi Arabia
por: Hurissi, Eman, et al.
Publicado: (2022)

Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application
por: Torikai, Hiroki, et al.
Publicado: (2016)

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
por: Ferrari, Samuele, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Disease. Unicenter Experience in a Multi-Ethnic Population.
por: Marziali, Marco, et al.
Publicado: (2009)

Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
por: de Azevedo, Júlia Teixeira Cottas, et al.
Publicado: (2021)

Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice
por: Everette, Kelcee A., et al.
Publicado: (2023)

Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019)

Genome editing for sickle cell disease: still time to correct?
por: Ceglie, Giulia, et al.
Publicado: (2023)

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
por: Gomez-Ospina, Natalia, et al.
Publicado: (2019)

Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
por: Pavani, Giulia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_plfiurnfjj17t9ad951l4lr3r9